The global biologics regulatory affairs market share analysis is witnessing unprecedented growth, poised to expand at a remarkable CAGR of 9.0%, with its market size expected to reach USD 2.42 billion by 2025. This surge is largely driven by the increasing pipeline of biologic therapies and biosimilars, compelling manufacturers to outsource regulatory affairs to leading …